Sponsors

Human papillomavirus vaccination

Analysis indicates that rates of high-grade cervical lesions decreased in young US women after vaccines were made available to protect against human papillomavirus (HPV), but the trend may be due in part to changes in cervical cancer screening recommendations.

CDC/Judy Schmidt; James Gathany

Published in the journal Cancer, the study illustrates some of the challenges in monitoring a vaccine’s impact during a time of concurrent changes in screening. More than half of high-grade cervical lesions that can lead to cancer are caused by persistent HPV infection that can be prevented if a person receives an HPV vaccine. Monitoring trends in the incidence of these lesions is helpful for evaluating the impact of HPV vaccination.

Latest Issues

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025

Annual SHOT Symposium

Hilton Birmingham Metropole Hotel, B40 1P
11 July 2025